Home › Funds › ARMISTICE CAPITAL, LLC › MGNX
ARMISTICE CAPITAL, LLC position in MGNX
MACROGENICS INC · Health Care
ARMISTICE CAPITAL, LLC reported holding 5,006,752 shares of MGNX (MACROGENICS INC) in its Q2 2026 13F filing — a position valued at US$23.1M, representing 0.30% of its reported portfolio and ranking #48 among its reported holdings. ARMISTICE CAPITAL, LLC has disclosed MGNX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How ARMISTICE CAPITAL, LLC's MGNX position evolved
ARMISTICE CAPITAL, LLC first disclosed a stake in MGNX in Q3 2023 at 4,712,000 shares (US$22.0M). The position peaked in Q4 2023 at 4,572,000 shares, worth US$44.0M. Across 12 filings, ARMISTICE CAPITAL, LLC increased the stake 3 time(s), trimmed it 5 time(s) and left it unchanged 3 time(s). The most recent filing (Q2 2026) shows 5,006,752 shares valued at US$23.1M — a reduction of -1,005,248 shares quarter over quarter.. Notable position changes include a 48% trim in Q1 2024 (shares fell 71% over the following quarter), a 150% increase in Q2 2024 (shares fell 23% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 4.71M | $21.96M | New |
| Q4 2023 | 4.57M | $43.98M | Reduce |
| Q1 2024 | 2.40M | $35.33M | Reduce |
| Q2 2024 | 6.00M | $25.50M | Add |
| Q3 2024 | 6.26M | $20.59M | Add |
| Q4 2024 | 6.28M | $20.40M | Hold |
| Q1 2025 | 6.30M | $8.00M | Hold |
| Q2 2025 | 5.96M | $7.21M | Reduce |
| Q3 2025 | 5.96M | $10.01M | Hold |
| Q4 2025 | 6.32M | $10.18M | Add |
| Q1 2026 | 6.01M | $17.37M | Reduce |
| Q2 2026 | 5.01M | $23.13M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About MGNX and 13F data
MGNX (MACROGENICS INC) is a Health Care company. 22 other funds we track also report a position in MGNX. Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
More on ARMISTICE CAPITAL, LLC
FAQ
How long has ARMISTICE CAPITAL, LLC held MGNX?
ARMISTICE CAPITAL, LLC has disclosed MGNX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is ARMISTICE CAPITAL, LLC's current position in MGNX?
As of Q2 2026, ARMISTICE CAPITAL, LLC holds 5.01M shares of MGNX (MACROGENICS INC), valued at $23.13M, representing 0.30% of its reported portfolio and ranking #48.
Has ARMISTICE CAPITAL, LLC been buying or selling MGNX?
In the latest 13F filing (Q2 2026), ARMISTICE CAPITAL, LLC reduced its position in MGNX. The position peaked in Q4 2023 at 4.57M shares.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.